Lifetime costs of the top five cancers in Taiwan

Lang, Hui Chu; Wu, Shi Liang

doi:10.1007/s10198-011-0307-1

Cited by 20 publications

(15 citation statements)

References 25 publications

(25 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients with poor prognosis showed a higher suicide risk in our study, which is consistent with previous studies . In Taiwan, cancers such as the lung, liver, pancreas, and esophagus are cancers with poor prognosis and they also come with higher initial and average medical expenditure, which may lead to hopelessness; and hopelessness is strongly associated with suicidal risks in patients with cancer . Head and neck, esophageal, and lung cancers in male patients were associated with higher suicide risks, similar to the result from the United States, with the nasopharyngeal cancer having the highest risk for suicide in the female patients in Taiwan.…”

Section: Discussionsupporting

confidence: 90%

“…In Taiwan, the health care expenditure for patients with newly diagnosed cancer is high within the first year, with it hitting the highest in the first month after diagnosis and then drops rapidly until month 6, followed by a plateau to the end of second year . Medical expenditures are also higher for survivors with cancer diagnosis within 1 year than that thereafter in the United States .…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Impact of universal health coverage on suicide risk in newly diagnosed cancer patients: Population‐based cohort study from 1985 to 2007 in Taiwan

et al. 2017

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Discussionmentioning

confidence: 99%

Impact of universal health coverage on suicide risk in newly diagnosed cancer patients: Population‐based cohort study from 1985 to 2007 in Taiwan

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Our estimate of lifetime cost to the NHI also corroborates with another study using claims data from a single tertiary care medical centre in Taiwan during 1999e2002; the undiscounted average cost up to 10 years for lung cancer was NT$ 448 371 (1US$ ¼ NT$ 33 in 2002), which is equivalent to US$16 703 in 2010. 10 Thus, we tentatively concluded that the two datasets, TCR and NHIRD, and the method used in this study are valid. The resulting estimates may be useful in future health policy decisions, especially regarding cancer prevention programmes.…”

Section: Discussionmentioning

confidence: 59%

Estimation of benefit of prevention of occupational cancer for comparative risk assessment: methods and examples

et al. 2012

View full text Add to dashboard Cite

ObjectivesTo quantify the life years gained and financial savings by preventing a case of occupational cancer.MethodsThe authors retrieved data from the Taiwan Cancer Registry and linked them with the National Mortality Registry to estimate the survival functions for major occupational cancers: lung, pleural mesothelioma, urinary bladder and leukaemia. Assuming a constant excess hazard for each type of cancer, the authors extrapolated lifetime survival functions by the Monte Carlo method. For each patient with cancer, the authors simulated an age- and gender-matched person without cancer based on vital statistics of Taiwan to estimate life expectancy and expected years of life lost (EYLL). By using the reimbursement data from the National Health Insurance Research Database, the authors calculated the average monthly healthcare expenditures, which were summed to estimate the lifetime healthcare expenditures after adjusting for the corresponding monthly survival probability.ResultsA total of 51 408, 136, 12 891 and 5285 new cases of lung, pleural mesothelioma, bladder and leukaemia cancers, respectively, were identified during 1997–2005 and followed until the end of 2007. The EYLL was predicted to be 13.7±0.1, 18.9±0.7, 4.7±0.3 and 19.4±0.5 years for these cancers, respectively, and the lifetime healthcare expenditures with a 3% annual discount were predicted to be US$22 359, US$14 900, US$51 987 and US$59 741, respectively.ConclusionsThe burden of these occupational cancers, in terms of EYLL and lifetime healthcare expenditures, was substantial. Such estimates may provide useful empirical evidence for comparative risk assessment that can be applied in health policy-making and clinical decision-making.

show abstract

“…[4] A study ever showed that the average lifetime costs (10 years) for cervical cancer were NT$511,563 in Taiwan (in 2012 NTD, 1USD≠NTD 33). [5] …”

Section: Introductionmentioning

confidence: 99%

Pelvic inflammatory disease increases the risk of a second primary malignancy in patients with cervical cancer treated by surgery alone

Chiou

Chen²,

Lee

et al. 2016

Medicine

View full text Add to dashboard Cite

As the number of long-term cervical cancer survivors continues to increase because of improvements in treatment, concerns about second primary malignancy have grown. The high-risk area of second primary cancers in cervical cancer survivors is the pelvis. Pelvic inflammatory disease (PID) could be a useful marker for gynecological cancers. Thus, we designed a large-scale, nationwide, controlled cohort study to investigate whether PID or other risk factors increased the risk of second primary cancers in patients with cervical cancer treated by surgery alone.Between 2000 and 2010, a total of 24,444 cervical cancer patients were identified using the Registry Data for Catastrophic Illness and the National Health Insurance Research Database (NHIRD) of Taiwan. Patients who received definite surgery were selected. To exclude the effect on second primary malignancy by treatment modalities, all cervical patients who ever having received adjuvant or definite radiotherapy or chemotherapy for primary cervical cancer were excluded. Finally, 3860 cervical cancer patients treated by surgery alone without adjuvant treatments were analyzed.Cox proportional hazards model was used for multivariate analysis and the Kaplan–Meier method was used to assess the cumulative risks. Regarding the incidence of second primary cancers, the standardized incidence ratio (SIR) was used.The median follow-up time was 56.6 months. The 6-year cumulative risk of second primary cancers is 0.16% and 0.12% for PID and without PID, respectively. After adjustment for confounders, age of less than 50 years, the presence of diabetes mellitus, and PID were significantly positivity associated with the risk of second primary cancers. The hazard ratios (HRs) of age less than 50 years, diabetes mellitus, and PID were 1.38 (95% CI = 1.11–2.04), 1.40 (95% CI = 1.06–1.85), and 1.35 (95% CI = 1.00–1.81), respectively. A higher incidence of second primary cancers was observed in the genitals, bladder, and colon.In conclusion, the incidence of second primary cancers was higher in the genitals, bladder, and colon in patients with cervical cancer treated with surgery alone. The patients with PID had a higher risk of second primary cancers.

show abstract

Lifetime costs of the top five cancers in Taiwan

Cited by 20 publications

References 25 publications

Impact of universal health coverage on suicide risk in newly diagnosed cancer patients: Population‐based cohort study from 1985 to 2007 in Taiwan

Impact of universal health coverage on suicide risk in newly diagnosed cancer patients: Population‐based cohort study from 1985 to 2007 in Taiwan

Estimation of benefit of prevention of occupational cancer for comparative risk assessment: methods and examples

Pelvic inflammatory disease increases the risk of a second primary malignancy in patients with cervical cancer treated by surgery alone

Contact Info

Product

Resources

About